377 related articles for article (PubMed ID: 10329555)
1. Antigenic profile of African horse sickness virus serotype 4 VP5 and identification of a neutralizing epitope shared with bluetongue virus and epizootic hemorrhagic disease virus.
Martínez-Torrecuadrada JL; Langeveld JP; Venteo A; Sanz A; Dalsgaard K; Hamilton WD; Meloen RH; Casal JI
Virology; 1999 May; 257(2):449-59. PubMed ID: 10329555
[TBL] [Abstract][Full Text] [Related]
2. Identification of a linear neutralization domain in the protein VP2 of African horse sickness virus.
Martínez-Torrecuadrada JL; Casal JI
Virology; 1995 Jul; 210(2):391-9. PubMed ID: 7542417
[TBL] [Abstract][Full Text] [Related]
3. Definition of neutralizing sites on African horse sickness virus serotype 4 VP2 at the level of peptides.
Martínez-Torrecuadrada JL; Langeveld JPM; Meloen RH; Casal JI
J Gen Virol; 2001 Oct; 82(Pt 10):2415-2424. PubMed ID: 11562535
[TBL] [Abstract][Full Text] [Related]
4. Expression and characterization of the two outer capsid proteins of African horsesickness virus: the role of VP2 in virus neutralization.
Martinez-Torrecuadrada JL; Iwata H; Venteo A; Casal I; Roy P
Virology; 1994 Jul; 202(1):348-59. PubMed ID: 8009847
[TBL] [Abstract][Full Text] [Related]
5. Identification of antigenic regions on VP2 of African horsesickness virus serotype 3 by using phage-displayed epitope libraries.
Bentley L; Fehrsen J; Jordaan F; Huismans H; du Plessis DH
J Gen Virol; 2000 Apr; 81(Pt 4):993-1000. PubMed ID: 10725425
[TBL] [Abstract][Full Text] [Related]
6. Full protection against African horsesickness (AHS) in horses induced by baculovirus-derived AHS virus serotype 4 VP2, VP5 and VP7.
Martínez-Torrecuadrada JL; Díaz-Laviada M; Roy P; Sánchez C; Vela C; Sánchez-Vizcaíno JM; Casal JI
J Gen Virol; 1996 Jun; 77 ( Pt 6)():1211-21. PubMed ID: 8683209
[TBL] [Abstract][Full Text] [Related]
7. Production of monoclonal antibodies binding to the VP7 protein of African horse sickness virus.
Luciani M; Armillotta G; Ciarelli A; Ulisse S; Teodori L; Bortone G; Giamboi A; Monaco F; Tittarelli M; Di Ventura M; Iannetti L; Podaliri Vulpiani M; Di Febo T
J Virol Methods; 2019 Aug; 270():131-136. PubMed ID: 31095974
[TBL] [Abstract][Full Text] [Related]
8. Neutralizing epitopes of African horsesickness virus serotype 4 are located on VP2.
Burrage TG; Trevejo R; Stone-Marschat M; Laegreid WW
Virology; 1993 Oct; 196(2):799-803. PubMed ID: 7690505
[TBL] [Abstract][Full Text] [Related]
9. Antigenic structure of the capsid protein of rabbit haemorrhagic disease virus.
Martínez-Torrecuadrada JL; Cortés E; Vela C; Langeveld JP; Meloen RH; Dalsgaard K; Hamilton WD; Casal JI
J Gen Virol; 1998 Aug; 79 ( Pt 8)():1901-9. PubMed ID: 9714238
[TBL] [Abstract][Full Text] [Related]
10. Recombinant baculovirus-synthesized African horsesickness virus (AHSV) outer-capsid protein VP2 provides protection against virulent AHSV challenge.
Roy P; Bishop DH; Howard S; Aitchison H; Erasmus B
J Gen Virol; 1996 Sep; 77 ( Pt 9)():2053-7. PubMed ID: 8811002
[TBL] [Abstract][Full Text] [Related]
11. Evolutionary relationships among the gnat-transmitted orbiviruses that cause African horse sickness, bluetongue, and epizootic hemorrhagic disease as evidenced by their capsid protein sequences.
Iwata H; Yamagawa M; Roy P
Virology; 1992 Nov; 191(1):251-61. PubMed ID: 1329319
[TBL] [Abstract][Full Text] [Related]
12. Use of a gene-targeted phage display random epitope library to map an antigenic determinant on the bluetongue virus outer capsid protein VP5.
Wang LF; Du Plessis DH; White JR; Hyatt AD; Eaton BT
J Immunol Methods; 1995 Jan; 178(1):1-12. PubMed ID: 7530266
[TBL] [Abstract][Full Text] [Related]
13. In silico prediction and in vitro identification of bluetongue virus 4 VP5 protein B-cell epitopes.
Sun L; Sun EC; Yang T; Xu QY; Feng YF; Li JP; Sun J; Wang WS; Wei P; Wu DL
Appl Microbiol Biotechnol; 2014 Apr; 98(7):3033-47. PubMed ID: 24337223
[TBL] [Abstract][Full Text] [Related]
14. Comparative sequence analysis and expression of the M6 gene, encoding the outer capsid protein VP5, of African horsesickness virus serotype nine.
du Plessis M; Nel LH
Virus Res; 1997 Jan; 47(1):41-9. PubMed ID: 9037735
[TBL] [Abstract][Full Text] [Related]
15. New generation of African horse sickness virus vaccines based on structural and molecular studies of the virus particles.
Roy P; Sutton G
Arch Virol Suppl; 1998; 14():177-202. PubMed ID: 9785506
[TBL] [Abstract][Full Text] [Related]
16. Structural Protein VP2 of African Horse Sickness Virus Is Not Essential for Virus Replication In Vitro.
van Gennip RGP; van de Water SGP; Potgieter CA; van Rijn PA
J Virol; 2017 Feb; 91(4):. PubMed ID: 27903804
[TBL] [Abstract][Full Text] [Related]
17. B-cell epitopes of African horse sickness virus serotype 4 recognised by immune horse sera.
Mathebula EM; Faber FE; Van Wyngaardt W; Van Schalkwyk A; Pretorius A; Fehrsen J
Onderstepoort J Vet Res; 2017 Feb; 84(1):e1-e12. PubMed ID: 28281773
[TBL] [Abstract][Full Text] [Related]
18. Analysis of murine B-cell epitopes on bluetongue virus 12 nonstructural protein 1.
HaiXiu W; EnCheng S; QingYuan X; Tao Y; Qin Z; YuFei F; JunPing L; Shuang L; Liang S; Jing S; DongLai W
Appl Microbiol Biotechnol; 2015 Feb; 99(3):1309-21. PubMed ID: 25343975
[TBL] [Abstract][Full Text] [Related]
19. The complete sequence of four major structural proteins of African horse sickness virus serotype 6: evolutionary relationships within and between the orbiviruses.
Williams CF; Inoue T; Lucus AM; Zanotto PM; Roy P
Virus Res; 1998 Jan; 53(1):53-73. PubMed ID: 9617769
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
Manning NM; Bachanek-Bankowska K; Mertens PPC; Castillo-Olivares J
Vaccine; 2017 Oct; 35(44):6024-6029. PubMed ID: 28438410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
